Looking back, I feel like the AlphaFold 3 launch a month ago was a precursor to this move. The public-facing side of AlphaFold 3 ('AlphaFold Server') is severel

Looking back, I feel like the AlphaFold 3 launch a month ago was a precursor to this move. The public-facing side of AlphaFold 3 ('AlphaFold Server') is severely constrained; if you want the novel parts around drug binding prediction you need to pay Isomorphic Labs instead. https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/#drug-discovery https://blog.google/technology/ai/google-deepmind-isomorphic... I expect other developments to follow suite: a bit of R&D with a lot of hype and commercialisation.